News

Video

ASCRS 2025: Rotational stability and outcomes with 'monofocal plus' toric IOL with Gregory Moloney, FRANZCO, FRCSC

A study reports minimal rotation and improved near vision following implantation of the Eyhance toric lens.

Gregory Moloney, FRANZCO, FRCSC, presented a straightforward but impactful study evaluating a design modification in the Eyhance toric IOL at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California. "This study is simple. The message is really, really clear and quick," Moloney explained, setting the tone for his findings on rotational stability improvements.

The key change tested was the introduction of a frosted haptic, replacing the previous polished design. "We were looking to test whether or not a design modification in the Eyhance toric lens resulted in improved or better rotational stability," he said. Patients were assessed at day 1, week 1, and 3 months post-implantation.

The results were promising. In a cohort of 98 eyes from 65 patients, the mean IOL rotation was just 1.73 degrees. "The mean average IOL rotation was 1.73 degrees, which is really very acceptable," Moloney noted. Notably, 95% of patients experienced less than 5 degrees of rotation. "I think as surgeons that's reassuring for us that we can trust this platform," he added.

Beyond objective measurements, patient-reported outcomes were also encouraging. Using a near vision questionnaire, preoperative scores (typically around 20 to 23) dropped significantly to an average of 6 postoperatively, suggesting that "near vision tasks were perceived to be easier after implantation of this lens."

Summing up the study’s practical impact, Moloney stated, "All we wanted to know personally from our perspective was...can we trust this lens to be rotationally stable?" His conclusion was confident: "Surgeons can feel reassured that a rotation rate of under 5 degrees in almost every patient...is a stable platform."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Š 2025 MJH Life Sciences

All rights reserved.